Annual Operating Expenses
$8.66 M
-$2.21 M-20.32%
December 1, 2023
Summary
- As of February 7, 2025, REVB annual total operating expenses is $8.66 million, with the most recent change of -$2.21 million (-20.32%) on December 1, 2023.
- REVB annual operating expenses is now -76.38% below its all-time high of $36.65 million, reached on December 1, 2019.
Performance
REVB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$1.80 M
-$725.70 K-28.77%
September 1, 2024
Summary
- As of February 7, 2025, REVB quarterly total operating expenses is $1.80 million, with the most recent change of -$725.70 thousand (-28.77%) on September 1, 2024.
- Over the past year, REVB quarterly operating expenses has dropped by -$725.70 thousand (-28.77%).
- REVB quarterly operating expenses is now -72.72% below its all-time high of $6.59 million, reached on March 31, 2022.
Performance
REVB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
REVB Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.3% | -28.8% |
| 3 y3 years | - | -28.8% |
| 5 y5 years | -75.0% | -28.8% |
REVB Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.6% | at low | -72.7% | +49.8% |
| 5 y | 5-year | -76.4% | at low | -72.7% | +49.8% |
| alltime | all time | -76.4% | at low | -72.7% | +49.8% |
Revelation Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.80 M(-28.8%) |
| Jun 2024 | - | $2.52 M(+32.6%) |
| Mar 2024 | - | $1.90 M(-18.2%) |
| Dec 2023 | $8.66 M(-20.3%) | $2.33 M(-16.3%) |
| Sep 2023 | - | $2.78 M(+43.7%) |
| Jun 2023 | - | $1.93 M(+19.3%) |
| Mar 2023 | - | $1.62 M(+33.0%) |
| Dec 2022 | $10.86 M | $1.22 M(+1.6%) |
| Sep 2022 | - | $1.20 M(-35.5%) |
| Jun 2022 | - | $1.86 M(-71.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $6.59 M(+70.8%) |
| Dec 2021 | $11.95 M(-67.4%) | $3.86 M(+26.7%) |
| Sep 2021 | - | $3.04 M(+24.7%) |
| Jun 2021 | - | $2.44 M(-6.4%) |
| Mar 2021 | - | $2.61 M |
| Dec 2019 | $36.65 M(+5.7%) | - |
| Dec 2018 | $34.67 M(+10.7%) | - |
| Dec 2017 | $31.33 M(+63.9%) | - |
| Dec 2016 | $19.12 M(+44.5%) | - |
| Dec 2015 | $13.23 M | - |
FAQ
- What is Revelation Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Revelation Biosciences?
- What is Revelation Biosciences annual operating expenses year-on-year change?
- What is Revelation Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Revelation Biosciences?
- What is Revelation Biosciences quarterly operating expenses year-on-year change?
What is Revelation Biosciences annual total operating expenses?
The current annual operating expenses of REVB is $8.66 M
What is the all time high annual operating expenses for Revelation Biosciences?
Revelation Biosciences all-time high annual total operating expenses is $36.65 M
What is Revelation Biosciences annual operating expenses year-on-year change?
Over the past year, REVB annual total operating expenses has changed by -$2.21 M (-20.32%)
What is Revelation Biosciences quarterly total operating expenses?
The current quarterly operating expenses of REVB is $1.80 M
What is the all time high quarterly operating expenses for Revelation Biosciences?
Revelation Biosciences all-time high quarterly total operating expenses is $6.59 M
What is Revelation Biosciences quarterly operating expenses year-on-year change?
Over the past year, REVB quarterly total operating expenses has changed by -$725.70 K (-28.77%)